Therefore, we have been screening potential anti-cancer agents by assessing inhibitory activity for the gene expression of FABP5. Thus, the compounds which suppress the expression of FABP5 might be promising chemopreventive agents against prostate cancer metastasis. Here, FABP5 is linked to prostate cancer.